<DOC>
	<DOCNO>NCT00320567</DOCNO>
	<brief_summary>The purpose study evaluate effect norgestimate/ethinyl estradiol lumbar spine ( L1-L4 ) total hip bone mineral density ( BMD ) pediatric subject anorexia nervosa .</brief_summary>
	<brief_title>The Effect Norgestimate/Ethinyl Estradiol Bone Density Pediatric Subjects With Anorexia Nervosa</brief_title>
	<detailed_description>Although oral contraceptive prescribe effort prevent bone loss adolescent anorexia nervosa , previous definitive placebo-controlled study evaluate effectiveness oral contraceptive treatment bone mineral density pediatric female anorexia nervosa . This randomized ( patient assign different treatment base chance ) , multicenter , double-blind ( neither patient physician know whether drug placebo take , dosage ) , placebo-controlled study evaluate bone mineral density pediatric patient anorexia nervosa follow treatment norgestimate/ethinyl estradiol placebo 13 consecutive 28-day cycle . Norgestimate/Ethinyl Estradiol package 28-day blistercard . Each tablet contain follow : ) Days 1-7 0.180 mg norgestimate/0.035 mg ethinyl estradiol b ) Days 8-14 0.215 mg norgestimate/0.035 mg ethinyl estradiol c ) Days 15-21 0.250 mg norgestimate/0.035 mg ethinyl estradiol ) Days 22-28 inactive tablet ; One tablet take daily mouth . After 28 day , next cycle start follow day without interruption . Color-matched placebo tablet identically pack</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norgestimate</mesh_term>
	<mesh_term>Norgestrel</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Patients must monthly period health status consistent anorexia nervosa meet modify DSMIV ( Diagnostic Statistical Manual Mental Disorders ) guideline anorexia nervosa must discontinue follow prior Baseline visit : hormonal contraceptive 3 month hormonal intrauterine device ( IUDs ) 1 month NORPLANT 3 month DepoProvera depot hormone injection , 6 month Lupron , Lupron Depot 3.75 mg 7.5 mg , Synarel , Zoladex , Cetrotide 3 month Lupron Depot 11.25 mg , 15 mg , 22.5 mg , 30 mg 6 month nonsmoker smoke &lt; = 15 cigarette per day must agree use reliable nonhormonal alternate method birth control study History presence disorder commonly accept contraindication steroid hormonal therapy include limit follow active history deep vein thrombophlebitis thromboembolytic disorder hypercoagulation disorder , cerebral vascular coronary artery disease , uncontrolled hypertension , migraine focal aura , benign malignant liver tumor develop use oral contraceptive estrogencontaining product , know suspected carcinoma body system , diabetes mellitus vascular involvement recent history alcohol substance abuse patient primary amenorrhea ( abnormal suppression absence menstruation ) opinion physician , appropriate candidate hormonal therapy ( eg , grown acceptable adult height ) subject suicidal patient receive experimental drug and/or use experimental device within 30 day start study .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>anorexia nervosa</keyword>
	<keyword>pediatric</keyword>
</DOC>